Caxton Associates (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Valaris
VAL
|
+$24.3M |
| 2 |
Moderna
MRNA
|
+$9.63M |
| 3 |
iShares Silver Trust
SLV
|
+$9.23M |
| 4 |
T-Mobile US
TMUS
|
+$9.02M |
| 5 |
Noble Corp
NE
|
+$6.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$107M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$29M |
| 3 |
Aptiv
APTV
|
+$22.6M |
| 4 |
Microsoft
MSFT
|
+$20.8M |
| 5 |
Amazon
AMZN
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.71% |
| 2 | Healthcare | 23.44% |
| 3 | Consumer Discretionary | 12.31% |
| 4 | Materials | 12.15% |
| 5 | Industrials | 5.2% |
Similar funds
Caxton Associates (New York)'s Q2 2022 Portfolio in Review
As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Caxton Associates (New York) withdrew a net $36.8M in Q2 2022, closing 269 positions and reducing 90 holdings. Its most notable exit was Tesla, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Caxton Associates (New York) opened a new position in Valaris worth $19.1M.
- Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
- Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
- Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
- Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
- Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
- Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
- Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.
Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.